Biologics Archives - Remedy GPO

Our Mission
Why Choose Us
Insights & Solutions
Partnerships
Blog
Contact

Standing Together Against Policy Changes: Advocacy Resources for Remedy GPO Members

Biosimilar Adoption in 2026: What Every Specialty Practice Needs to Know

Biosimilar Adoption in 2026: What Every Specialty Practice Needs to Know

Optimizing Infusion Center Capacity in 2026: Strategies to Do More Without Expanding Footprint

Optimizing Infusion Center Capacity in 2026: Strategies to Do More Without Expanding Footprint

Faster Rituximab Infusions in Rheumatology: Evidence Supports Safe, Efficient Care Delivery

Faster Rituximab Infusions in Rheumatology: Evidence Supports Safe, Efficient Care Delivery

The Hidden Financial Risk of Biologic Therapy Volatility in Neurology

The Hidden Financial Risk of Biologic Therapy Volatility in Neurology

2026 PBM Formulary Exclusions: What Independent Practices Need to Know About Biosimilars, Net Pricing, and Market Access

2026 PBM Formulary Exclusions: What Independent Practices Need to Know About Biosimilars, Net Pricing, and Market Access

Harnessing Patient Experience Data to Improve Infusion Practice Performance

Harnessing Patient Experience Data to Improve Infusion Practice Performance

Contact Us

Full Name

Email

Company

Phone number

Message

A member-based organization created to better serve the needs of in-office infusion providers and their patients receiving biologics and specialty pharmaceuticals.

11233 Shadow Creek Parkway, Suite 303, Pearland, TX 77584, USA

LinkedIn

X

Remedy GPO
Our Mission
Why Choose Us
Insights & Solutions
Partnerships
Contact Us
Blog
Privacy Notice and Terms of Use

© 2026 Remedy GPO. All rights reserved. Powered by Zenga Solutions Inc.